Showing results (211-220 of 470) with videos related to
Sort By:
Pageof 47
ESMO Open|May 2, 2018
Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record data setAxel Grothey, Takayuki Yoshino, Gyorgy Bodoky, et al.NPJ Breast Cancer|December 28, 2018
Prognostic characteristics in hormone receptor-positive advanced breast cancer and characterization of abemaciclib efficacyAngelo Di Leo, Joyce O'Shaughnessy, George W Sledge, et al.Plos One|July 21, 2012
Gemcitabine and irinotecan as first-line therapy for carcinoma of unknown primary: results of a multicenter phase II trialShernan G Holtan, Preston D Steen, Nathan R Foster, et al.Frontiers in Oncology|March 27, 2025
Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b studySara M Tolaney, Komal Jhaveri, Teresa Helsten, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 25, 2025
Lorlatinib and neurocognitive adverse events: characterization, risk factors, and the potentially mitigative role of social supportRyan Brown, Katie E Smith, Mohamed M Shanshal, et al.International Journal of Cancer|May 26, 2020
Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumorsMohamed E Salem, J Nicholas Bodor, Alberto Puccini, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2010
Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741Howard L McLeod, Daniel J Sargent, Sharon Marsh, et al.Future Oncology (London, England)|April 13, 2025
ELAINE 3: phase 3 study of lasofoxifene plus abemaciclib to treat ER+/HER2-, ESR1-mutated, metastatic breast cancerMatthew P Goetz, Seth A Wander, Thomas Bachelot, et al.Breast Cancer Research and Treatment|October 2, 2019
Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissuesJohn R Hawse, Jodi M Carter, Kirsten G M Aspros, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
Coprescription of tamoxifen and medications that inhibit CYP2D6Kostandinos Sideras, James N Ingle, Matthew M Ames, et al.Pageof 47